TMEM219 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.573800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.396400E-01
Normal-vs-Stage2
3.206800E-01
Normal-vs-Stage3
7.417000E-01
Normal-vs-Stage4
1.298560E-01
Stage1-vs-Stage2
9.340600E-01
Stage1-vs-Stage3
3.767400E-01
Stage1-vs-Stage4
8.973400E-01
Stage2-vs-Stage3
1.131820E-01
Stage2-vs-Stage4
7.723200E-01
Stage3-vs-Stage4
1.623840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.984400E-01
Normal-vs-AfricanAmerican
4.953400E-01
Normal-vs-Asian
9.534000E-02
Caucasian-vs-AfricanAmerican
8.325600E-01
Caucasian-vs-Asian
7.420200E-02
AfricanAmerican-vs-Asian
1.934790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.139000E-01
Normal-vs-Female
4.387600E-01
Male-vs-Female
3.095800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.811600E-01
Normal-vs-Age(41-60Yrs)
3.378400E-01
Normal-vs-Age(61-80Yrs)
4.100400E-01
Normal-vs-Age(81-100Yrs)
1.261600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.530600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.264000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.288000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.723000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.104790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.267000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.790400E-01
Normal-vs-Daily Drinker
2.220400E-01
Normal-vs-Weekly Drinker
3.866000E-01
Normal-vs-Occasional Drinker
2.811400E-01
Normal-vs-Social Drinker
5.342800E-01
Non Drinker-vs-Daily Drinker
1.782800E-01
Non Drinker-vs-Weekly Drinker
9.570200E-01
Non Drinker-vs-Occasional Drinker
5.426600E-01
Non Drinker-vs-Social Drinker
6.625200E-01
Daily Drinker-vs-Weekly Drinker
2.687000E-01
Daily Drinker-vs-Occasional Drinker
4.895400E-01
Daily Drinker-vs-Social Drinker
1.153050E-01
Weekly Drinker-vs-Occasional Drinker
6.070400E-01
Weekly Drinker-vs-Social Drinker
6.223600E-01
Occasional Drinker-vs-Social Drinker
3.066000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.450000E-01
Normal-vs-Grade 2
1.957520E-02
Normal-vs-Grade 3
2.259900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.436800E-01
Grade 1-vs-Grade 3
2.923000E-01
Grade 1-vs-Grade 4
2.450000E-01
Grade 2-vs-Grade 3
9.166600E-01
Grade 2-vs-Grade 4
1.957520E-02
Grade 3-vs-Grade 4
2.259900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.676000E-01
Normal-vs-NonDiabetic
2.572600E-01
Diabetic-vs-NonDiabetic
4.181000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.608400E-02
Normal-vs-NoPancreatitis
3.757800E-01
Pancreatitis-vs-NoPancreatitis
1.957990E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.177400E-01
Normal-vs-N1
3.591800E-01
N0-vs-N1
4.808800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.401400E-01
Normal-vs-TP53-NonMutant
7.913400E-01
TP53-Mutant-vs-TP53-NonMutant
2.44159999999161E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
